DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wish to give notice that Phebra has updated the packaging of Potassium Chloride 22.3% Concentrated Injection as follows: Potassium Chloride 22.3% Concentrated Injection Potassium Chloride 2.23 g/10 mL ARTG 23073 This product…
Read more
HPS Pharmacies wish to give notice that Fresenius Kabi, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Sodium Chloride 0.9% Freeflex bags as follows: Sodium Chloride 0.9% Freeflex…
Read more
HPS Pharmacies wish to give notice that Viatris, in consultation with the Therapeutic Goods Administration (TGA), has initiated a product defect correction for Midazolam Alphapharm injection (now branded as Midazolam Viatris injection) as follows:…
Read more
Further to DrugAlert volume 885, HPS Pharmacies wish to provide an update on the availability of morphine oral solution. Ordine® Oral Solution is set to be discontinued, with all wholesale supplies expected to be…
Read more
HPS Pharmacies wish to advise that Bayer Australia is experiencing a supply interruption for Mirena® as follows: Mirena® IUD Levonorgestrel 52mg ARTG 73027 Normal supplies of Mirena® are expected to resume by early September…
Read more
HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for lidocaine ampoules as follows: Lignocaine Injection Lidocaine (lignocaine) HCl 1% (50mg/5mL) ARTG 49296 Lignocaine Injection Lidocaine (lignocaine) HCl 2% (100mg/5mL) ARTG…
Read more
